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Background: As the world’s largest developing country, China has entered into the epidemiological phase
characterized by high life expectancy and high morbidity and mortality from chronic diseases. Cardiovascular
diseases, chronic obstructive pulmonary diseases, and malignant tumors have become the leading causes of death
since the 1990s. Constant payments for maintaining the health status of a family member who has chronic diseases
could exhaust household resources, undermining fiscal support for other necessities and eventually resulting in
poverty. The purpose of this study is to probe to what degree health expenditure for chronic diseases can
impoverish rural families and whether the New Cooperative Medical Scheme can effectively protect families with
chronic patients against catastrophic health expenditures.
Methods: We used data from the 4th National Health Services Survey conducted in July 2008 in China. The rural
sample we included in the analysis comprised 39,054 households. We used both households suffering from medical
impoverishment and households with catastrophic health expenditures to compare the financial protection for
families having a chronic patient with different insurance coverage statuses. We used a logistic regression model
to estimate the impact of different benefit packages on health financial protection for families having a
chronic patient.
Results: An additional 10.53% of the families with a chronic patient were impoverished because of healthcare
expenditure, which is more than twice the proportion in families without a chronic patient. There is a higher
catastrophic health expenditure incidence in the families with a chronic patient. The results of logistic regression
show that simply adding extra benefits did not reduce the financial risks.
Conclusions: There is a lack of effective financial protection for healthcare expenditures for families with a chronic
patient in rural China, even though there is a high coverage rate with the New Cooperative Medical Schemes.
Given the coming universal coverage by the New Cooperative Medical Scheme and the increasing central
government funds in the risk pool, effective financial protection for families should be possible through
systematic reform of both financing mechanisms and payment methods.
Keywords: Financial protection, Chronic disease, Rural areas, Poverty, ChinaBackground
Farmers in low income countries live in a risky world.
Like drought, flood, and fluctuations in the produce
markets, ill health is identified as a major cause of im-
poverishment in the rural societies of developing coun-
tries. There is much literature that documents the
vicious circle of disease and poverty [1-7]. As a response
to this evidence, there are an increasing number of* Correspondence: jdma@mail.hust.edu.cn
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reproduction in any medium, provided the ordeveloping countries that have started health protection
programs for their people. Because of limited financial
budgets, these health programs largely focus on protect-
ing against catastrophic episodes, for example, hospitali-
zations inducing large medical expenditures in a short
term. However, for those who earn their livings based on
their own labor and who have limited household
resources, it can also be devastating to encounter
chronic conditions without effective financial protec-
tions. The constant payments for maintaining the health
status of a family member who has chronic diseases cantd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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poverty [8-17]. In the better-off developing countries,
the shifting epidemiological phase characterized by
increases both in life expectancy and prevalence rates of
chronic diseases may pose great challenges to the exist-
ing health protection system. In China, cardiovascular
diseases, chronic obstructive pulmonary diseases, and
malignant tumors have become the leading causes of
death for both urban and rural populations since the
1990s. The 4th National Health Service Survey (NHSS)
in 2008 documented a 17.1% prevalence rate of chronic
diseases in the sample populations of rural areas, which
is 4.94% higher than as reported in 2003 based on the
3rd NHSS data. Such a rapid change in disease spectrum
highlights the need for policymakers to reshape the
health protection system already in place. After the col-
lapse of the traditional health protection system in rural
society, the majority of Chinese farmers were exposed
unprotected to the uncertainty of medical care for about
two decades. Medical spending increased the number of
rural households living below the poverty line by 44%. It
was not until the year 2003 that the Chinese government
launched a new health protection plan for farmers - the
New Cooperative Medical Scheme (NCMS), a voluntary
medical insurance plan financed by the enrolled families,
local governments and the central government. This
plan drastically extended coverage to more than 90% of
the rural population and was expected to achieve univer-
sal coverage by the end of 2010. Though subsidized
heavily by the central government, the NCMS does not
have a one-size-fits-all detailed plan for implementation
across the country except for a couple of principles.
Operated by county administrations, the NCMS benefit
package and payment methods vary from area to area
[18-21]. Such institutional arrangements may offer flexi-
bility in resource allocation and the opportunity for
management innovation. Originally, the NCMS was
designed to protect against catastrophic health spending,
which meant it only covered for inpatient care. To meet
the increasing need for chronic care and mediate the
consequent economic impact to families, many NCMSs
began to incorporate outpatient care insurance or com-
bine it with a medical savings account. Some areas even
offer a special reimbursement for patients having
chronic diseases from certain conditions. However, we
would argue that, because of the lack of high-quality ad-
ministrative human resources at the county level, such
arrangements would only be a result of goodwill rather
than scientific, evidence-based policymaking. Based on
the data of the latest National Health Services Survey in
China, we will answer two questions in this paper: 1) to
what degree health spending as a result of the existence
of chronic diseases in families can impoverish them;




We used data from the 4th National Health Services Sur-
vey conducted in July 2008 in China. The National
Health Services Survey is a cross-sectional survey orga-
nized by the Centre for Health Statistics and Informa-
tion of the Ministry of Health in China. The survey
sample adopted multi-‐stage stratified random sampling
procedures and methods so that it could achieve max-
imum representation of the demographic and socioeco-
nomic characteristics of the whole population. The rural
sample that we included in this analysis comprised 39,
054 households; 13, 990 of them had at least one chronic
patient. Data used in this analysis was permitted by
China’s Ministry of Health Statistical Information Center.
Definition of a chronic patient
A chronic patient is someone who was reported to have
diabetes, hypertension, heart disease, malignant tumor,
or chronic obstructive pulmonary disease diagnosed by
doctors in the half year before the survey date. There are
certain reasons why we confined chronic illnesses to
these five disease clusters. First, they are the leading
causes of death and the top prevalent diseases in the
rural population in China. Second, we did not focus on
one specific disease because many patients actually had
one or more chronic co-morbidities. Third, focusing on
the five major chronic diseases could reduce the hetero-
geneity of financial outcomes pertaining to health status,
which may vary considerably from disease to disease.
Measuring financial catastrophe
Following the methodology used by the WHO health-
care financing program [22-25], we used two indicators
to estimate financial protection for families with chronic
patients: one was to calculate households below the pov-
erty line after healthcare payments out of pocket; the
other was to calculate the incidence of catastrophic
health expenditure.
1) Defining the poverty line and household subsistence
expenditure
A nondiscretionary amount of household financial
budget needs to be allocated to basic sustenance in a
society. We considered such nondiscretionary
spending as the household subsistence expenditure.
In our study, we used a food-based poverty line as
the household subsistence expenditure. First, we
identified households with food expenditure shares
of the total household expenditure between the 45th
and 55th percentiles. Then, we used equation (1) to
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where hf denotes household food expenditure; hs
denotes household size; β is a coefficient for
adjusting household sizes; and N is the number of
households we identified. In this study, β was set as
0.56 according to an estimation based on a multi-
countries analysis.
2) Defining household capacity to pay
Household capacity to pay reflects the freedom to
allocate resources to consumptions beyond
subsistence spending. We defined household capacity
to pay as the total household expenditure net of
subsistence spending. In some cases, households may
report food expenditures less than subsistence
spending. For such cases, we defined household
capacity to pay as the total household expenditure
net of food spending. Then, the ith household’s
capacity to pay (ci) can be calculated via
equation (2)
ci ¼ hei  hse if hse ≤ hfi
ci ¼ hei  hfi if hse > hfi ;

ð2Þ
where hei denotes the i
th household’s total
expenditure; hfi denotes the ith household’s food
expenditure.
3) Defining medical impoverishment
Medical impoverishment refers to non-poor
households becoming poor because of out-of-pocket
health spending. We defined an indicator, t, which
equals 1 when total household expenditure is equal
to or larger than subsistence spending but
household expenditure minus out-of-pocket
health payment is smaller than subsistence spending,
and 0 otherwise. Medical impoverishment





where N is the sample size.
4) Defining catastrophic health expenditure
Catastrophic health expenditure occurs when
out-of-pocket health spending exceeds the threshold
fraction of the household’s capacity to pay. We used
0.2 and 0.4 as threshold fractions in our study, but
will only report the results based on 0.4. We defined
an indicator p to denote the incidence ofcatastrophic health expenditure. Catastrophic





pi ¼ 1 if oopi=ci ≥0:4
pi ¼ 0 if oopi=ci < 0:4;

ð4Þ
where oopi is the out-of-pocket health payment of
the ith household.Comparing the different types of insurance coverage
In our dataset, there were 842 households with a chronic
patient not covered by any kind of NCMS. For those
who were covered by NCMSs, in spite of diversities,
their insurance coverage could be divided into 3 groups
according to different benefit package designs. We
summarize the features and proportions of these 4 kinds
of insurance coverage in Table 1. In the CATA group,
the insured are reimbursed only for hospitalization epi-
sodes, which is essentially catastrophic medical insur-
ance. In the CATAplusA group, besides reimbursement
for hospitalization episodes, the insured get reimburse-
ment for out-patient care. But in this case, there is usu-
ally a fairly low ceiling on the total reimbursement a
household can get. More than half of the sample house-
holds were in the CATAplusB group, in which the
insured can get extra chronic care compensation when
they have certain chronic diseases identified by the au-
thorities, besides the benefit package in the CATAplusA
group. The chronic care compensation is limited and
covers only a small fraction of the total health spending
of the eligible patients. We used both counts of house-
holds with medical impoverishment and of households
with catastrophic health expenditures to compare the fi-
nancial protection for families having a chronic patient
with different insurance coverage statuses.
We used a logistic regression model to estimate the
impact of different benefit packages on health financial
protection for families having a chronic patient.
ln
Pr y ¼ 1jzð Þ
1 Pr y ¼1jzð Þ
 
¼ δz þ βX þ α ð5Þ
where y is a dummy variable on catastrophic health ex-
penditure (CHE) (1, with CHE; 0 without CHE); z is a
dummy variable on family’s insurance coverage statuses
(3, with CATAplusB; 2, with CATAplusA; 1, with CATA;
0, uncovered) and δ is the coefficient of z; X is a vector
of controlling variables including household income,
areas, household size, household head’s education and
gender, etc.; β is a vector of parameters for X; α is a
constant.
Table 1 Features and proportion of 4 insurance coverage




Uncovered Not covered by any kinds of
NCMSs
2,696 6.90%
CATA Catastrophic medical insurance 3,439 8.81%
CATAplusA Catastrophic medical insurance




CATAplusB Catastrophic medical insurance
for inpatient care plus
reimbursement for outpatient







































Figure 1 Catastrophic health expenditure incidence by family
income quintile in rural China,2008.
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According to our calculation based on the full rural
household sample, subsistence expenditure per capita or
the poverty line was 2432.64 yuan (approx. 355.13 USD
in 2008). With this boundary line, 14.25% of the families
with chronic patients were poor, compared with 15.63%
of the families without chronic patients. However, after
paying for health costs, 24.78% of the families with
chronic patients were poor, compared with 20.79% of
the families without chronic patients. For those who
were not poor before health payments, the medical im-
poverishment incidence rate was much higher among
families with a chronic patient than the rate among fam-
ilies without a chronic patient. Table 2 also shows that
an additional 10.53% of the families with a chronic pa-
tient were impoverished because of paying for health
costs, which was more than twice the proportion in-
crease of the families without a chronic patient.
There was a higher catastrophic health expenditure in-
cidence in the families with a chronic patient (Figure 1).
The catastrophic health expenditure incidence rate var-
ied from 41.86% in the poorest quintile of families with
a chronic patient to 10.98% in the richest. The cata-
strophic health expenditure incidence rates in all families






















25,025 15.63 20.79 5.16the families with a chronic patient was more serious.
Figure 2 shows the medical impoverishment rate in
those who were not poor before health payment. The ex-
istence of a chronic patient increased the risk of being
impoverished in all income quintiles. The distribution of
medical impoverishment was fairly regressive in terms of
family income. Among families with a chronic patient in
the lowest income quintile, the medical impoverishment
prevalence was as high as 38.63%. But only 1.28% of
families with a chronic patient in the highest income
quintile were impoverished because of health spending.
Higher income lessened the gap of medical impoverish-
ment between families with and without a chronic pa-
tient. Obviously, the existence of a chronic patient
induced larger expenditures on health among families in
rural China. Although 94% of those families with a
chronic patient in our sample were covered by NCMSs,
the medical impoverishment and catastrophic health ex-
penditure incidence were still high. Can NCMS coverage
and different benefit designs make a difference for the
families with chronic conditions in terms of financial
protection? Table 3 shows some counterintuitive results.
In terms of poverty measurements, the lowest percent-
age change after payment for health expenses was in
those who were not covered by any kind of NCMS. This
result could be attributed to adverse selection in the




























Figure 2 Medical impoverishment by family income quintile in
rural China,2008.
Table 3 Effects of NCMS on financial protection for













Uncovered 842 13.78 21.26 7.48
CATA 1,135 22.47 31.81 9.34
CATAplusA 3,661 17.62 29.17 11.55
CATAplusB 8,352 11.70 22.25 10.55
Total 13,990 14.25 24.78 10.53
Table 5 Effects of different insurance coverage on




Z P [95% Conf.
Interval]
Household size 0.831 0.015 −10.480 0.000 0.803 0.860
Household income 0.999 0.000 −8.660 0.000 0.999 0.99
Insurance coverage Reference group: uncovered
CATA 0.748 0.100 −2.170 0.030 0.575 0.972
CATAplusA 1.174 0.122 1.540 0.123 0.957 1.440
CATAplusB 1.342 0.133 2.960 0.003 1.105 1.631
household head Gender 0.973 0.064 −0.410 0.680 0.856 1.106
Education level of
Household head
reference group :never went to school
Primary school 0.849 0.050 −2.770 0.006 0.756 0.953
middle school 0.677 0.046 −5.750 0.000 0.593 0.774
College or above 0.575 0.060 −5.280 0.000 0.469 0.706
member's self perceived
illness in 14 days
1.002 0.058 0.030 0.976 0.895 1.121
Hospitalization Episode 4.155 0.202 29.340 0.000 3.777 4.569
Located areas reference group : western China
central China 0.904 0.054 −1.680 0.094 0.804 1.017
eastern China 1.031 0.064 0.500 0.617 0.914 1.164
member's clinic visit
in 14 days
1.521 0.077 8.300 0.000 1.378 1.679
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plusB offered weaker financial protection than did
CATA, although those 2 groups were intended to meet
the needs of chronically ill patients. It is worth noticing
that the families only had the choice to enroll or not,
but no choice of different benefit packages once they
were enrolled. Table 4 illustrates the medical impover-
ishment by income quintile under the different insur-
ance coverage statuses. On average, the weakest group
for financial protection was CATAplusA, in which
14.18% of the non-poor families became poor after
health care payments. But for the lowest income quin-
tile, the weakest group for financial protection was CAT-
AplusB, in which 43.99% of the non-poor families
became poor after health care payments. On the con-
trary, CATA provided the weakest financial protection
for families in the highest income quintile. Table 5
shows the results of logistic regression. After controlling
for household size, income, gender of household heads,
education level of household heads, family member self-
perceived illness in the previous 14 days, hospitalization
episodes in the previous 1 year, and member clinical vis-
its in the previous 14 days, families in the CATAplusB
group still had excess risk (OR: 1.342; 95%CI: 1.105,
1.631) for encountering catastrophic health expenditures
compared with families uncovered by NCMSs. CATA
offered significant financial protection against cata-
strophic health expenditures compared with the uncov-
ered group (OR: 0.748; 95%CI: 0.575, 0.972). AndTable 4 Medical impoverishment rate (%) by income




uncovered CATA CATAplusA CATAplusB
lowest <6500 37.21 41.01 41.49 43.99
2nd >=6500 17.57 24.29 26.49 19.92
3rd >=10000 7.73 9.33 9.46 9.13
4th >=15000 1.79 4.39 4.52 4.59
5th >=23000 0.46 1.14 1.07 0.93
Total - 8.68 13.01 14.18 11.79CATAplusA had slightly negative impacts on protecting
families with a chronic patient from catastrophic health
expenditure (OR: 1.174; 95%CI: 0.957, 1.440), although
not statistically significantly.
Discussion
The prevalence of chronic diseases in rural China is
quite high now. And the figure is projected to be higher
in future because of the accelerating population aging
process induced by the one –child policy in China.
Chronic diseases not only have severely negative impacts
on patients’ quality of life, but also cause great losses of
welfare to their families. Although the economic conse-
quences of chronic diseases for a family are beyond the
direct medical costs, sufficient financial protection
against constant outlays for maintaining the health sta-
tus of a chronic patient is critical for families to avoid
poverty or to rebound from it. In our sample, more than
1/3 of the families had at least one chronic patient. Our
results show that those families were at higher risk to be
impoverished or experience catastrophic health expend-
iture than the families without a chronic patient. A
lower pre-payment poverty rate among families with a
chronic patient indicates that they would have been bet-
ter off if there had been no chronic conditions. Health
spending reversed the distribution of poverty between
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families with and without a chronic patient in rural
China, the distribution of medical impoverishment and
catastrophic health expenditure were regressive in terms
of family income. However, such a regressive distribution
pattern was much more serious in families affected by
chronic diseases. The non-poor families with a chronic
patient in the lowest family income quintile were 30
times more likely than those in the highest family in-
come quintile to be impoverished because of health
spending. Those who had less family income were more
likely to be afflicted by catastrophic health expenditures.
Considering the long term effects of chronic diseases,
such a regressive distribution indicates that the poorer
families with chronic conditions would face a dilemma
to either let the health spending squeeze out subsistence
spending or to restrict their chronic patient from access
to essential healthcare, both of which eventually lead to
devastating impacts on livelihood security. Given that
more than 94% of the sampled families were covered by
the New Cooperative Medical Schemes, these should
have offered a certain financial protection for the fam-
ilies with a chronic patient. However, our results show
that the families covered by NCMSs were at higher risk
to be impoverished than the uncovered. Given the possi-
bility of adverse selection in the voluntary insurance
schemes, or that some of the uncovered may be rich
enough to self-insure, the credibility of this result may
be undermined by these potential selection biases.
Nonetheless, this is consistent with other reports of the
impact of NCMS [26-30]. For instance, Wagstaff and
Lindelow found that health insurance in China increases
the risk of high and catastrophic spending using probit
regression models based on the data of China Health
and Nutrition Survey. Wagstaff and Lindelow reported
in another study that the NCMS had not reduced out-‐
of-‐pocket spending for either outpatient or inpatient
visits. Our results also indicate that simply adding extra
benefit packages to catastrophic medical insurance does
not necessarily result in more effective financial protec-
tion. Winnie Yip and William Hsiao argued that the
weak performance of NCMSs in financial protection
could be largely attributed to ignorance of the high
prevalence of chronic diseases and of the corresponding
medical expenditure pattern in policy design. Adding
extra insurance for outpatient care or compensation for
chronic care of certain diseases should have been a re-
sponse to such arguments. But these decisions were
largely made by administrators at a county level, who
are in lack of specific knowledge in designing health fi-
nancing system. The corresponding policy change could
not be delivered in a systematic way. Without conson-
ance of payment reform and effective disease manage-
ment, the effect of an extra benefit package for chronicpatients will be decoupled by moral hazard or other se-
quent behavior changes on both supply and demand
sides. There are several limitations of our study in terms
of policy implications. First, although our study has
roughly shed light on how different benefit package
designs potentially affect financial protection for families
with a chronic patient in rural China, methodologically
it is not a strict evaluation of the effectiveness of the
new cooperative medical schemes. There are likely to be
selection biases in our study. However, this limitation
may be mitigated to some extent by the high enrollment
rate in our sample. Second, our dataset does not contain
information on the behaviors of patients and physicians.
We cannot provide empirical evidence that behavior
changes lead to overuse and cost inflation which could
explain the excess financial risk in more generous bene-
fit packages. Third, our data come from a cross-sectional
survey so that we cannot take into account poverty dy-
namics caused by the long-term effects of chronic
diseases.
Conclusions
In summary, there is a lack of effective financial health
protection for families with a chronic patient in rural
China, even though there is a high coverage rate with
the New Cooperative Medical Schemes. Driven by the
high prevalence of chronic disease and the desire for a
better quality of life, the demand for chronic care will be
consistently increasing. This would be a great challenge
for the effectiveness and sustainability of the rural health
insurance system in China. Given the coming universal
coverage of NCMS and the increasing central govern-
ment funds in the risk pool, effective financial protection
for families should be provided through systematic re-
form of both financing mechanisms and payment
methods.
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